Viridiana Arellano
Acute Care · Las Cruces, NMNPI 1063193969
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 152 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,520, 3.1 times the $486 reported in 2023. Among acute care clinicians in NM with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 152 payments — averaging $22.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$506
- AstraZeneca$486
- GSK$450
- Sanofi$359
- United Therapeutics Corporation$245
- Grifols USA, LLC$244
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,470100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 15 | $506 |
| AstraZeneca | 16 | $486 |
| GSK | 29 | $450 |
| Sanofi | 16 | $359 |
| United Therapeutics Corporation | 4 | $245 |
| Grifols USA, LLC | 15 | $244 |
| Viatris Specialty LLC | 10 | $203 |
| Regeneron Healthcare Solutions, Inc. | 10 | $188 |
| Mylan Specialty L.p. | 8 | $155 |
| Abiomed | 1 | $125 |
| Verona Pharma, Inc. | 5 | $124 |
| Electromed, Inc. | 6 | $73 |
| Actelion Pharmaceuticals US, Inc. | 3 | $66 |
| Merck | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| Baxter Healthcare | 2 | $46 |
| Insmed, Inc. | 2 | $34 |
| Philips North America LLC | 2 | $29 |
| Bayer | 1 | $14 |
| Novartis | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,479 in reported general payments places this provider in the 90th percentile of 132 acute care providers in New Mexico.
Other acute care in Las Cruces
- Bernadette HerreraLas Cruces$6K
- Susann RavessoudLas Cruces$5K
- Elicia CurrierLas Cruces$3K
- Mary YoungerLas Cruces$2K
- Danielle RuizLas Cruces$2K
- Edward CollinsLas Cruces$2K
- Tonee GonzalezLas Cruces$1K
- Taylor MartinezLas Cruces$1K
- Matthew FrancoLas Cruces$724
- Celina DoyleLas Cruces$403
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.